ASH 2024 | Ongoing CAR-T stewardship: monitoring the long-term safety of these therapies & reassuring patients
David Miklos
• 6 Dec 2024
David Miklos, MD, PhD, Stanford University, Stanford, CA, comments on the importance of ongoing CAR-T stewardship, highlighting the need to monitor for long-term toxicities in CAR-T-treated patients, particularly secondary malignancies. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
